China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) ROCE % : -0.11% (As of Dec. 2024)

View and export this data going back to 2012. Start your Free Trial

What is China Resources Boya Bio-pharmaceutical Group Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. China Resources Boya Bio-pharmaceutical Group Co's annualized ROCE % for the quarter that ended in Dec. 2024 was -0.11%.

China Resources Boya Bio-pharmaceutical Group Co ROCE % Historical Data

The historical data trend for China Resources Boya Bio-pharmaceutical Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Boya Bio-pharmaceutical Group Co ROCE % Chart

China Resources Boya Bio-pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROCE %

Get a 7-Day Free Trial

8.11

8.04

7.44

4.82

6.37

China Resources Boya Bio-pharmaceutical Group Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
ROCE %	Get a 7-Day Free Trial															-11.81	9.47	10.20	5.96	-0.11

China Resources Boya Bio-pharmaceutical Group Co ROCE % Calculation

China Resources Boya Bio-pharmaceutical Group Co's annualized ROCE % for the fiscal year that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2024 )		(A: Dec. 2023 )		(A: Dec. 2024 )
	=	478.378	/	( ( (7828.9 - 456.447)	+	(8401.145 - 750.376) )	/ 2 )
	=	478.378	/	( (7372.453	+	7650.769)	/ 2 )
	=	478.378	/	7511.611
	=	6.37 %

China Resources Boya Bio-pharmaceutical Group Co's ROCE % of for the quarter that ended in Dec. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2024 )		(Q: Sep. 2024 )		(Q: Dec. 2024 )
	=	-8.692	/	( ( (8157.947 - 548.573)	+	(8401.145 - 750.376) )	/ 2 )
	=	-8.692	/	( ( 7609.374	+	7650.769 )	/ 2 )
	=	-8.692	/	7630.0715
	=	-0.11 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

China Resources Boya Bio-pharmaceutical Group Co (SZSE:300294) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

China Resources Boya Bio-pharmaceutical Group Co ROCE % Related Terms

Thank you for viewing the detailed overview of China Resources Boya Bio-pharmaceutical Group Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

China Resources Boya Bio-pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » China Resources Boya Bio-pharmaceutical Group Co Ltd (SZSE:300294) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Number 333, Huiquan Road, High-tech Industrial Park, Jiangxi Province, Fuzhou, CHN, 344000

Website

https://www.china-boya.com

China Resources Boya Bio-pharmaceutical Group Co Ltd is a China-based medical industry group that integrates biochemical drugs, chemical drugs, and active pharmaceutical ingredients. It is engaged in the provision of medical and health products and services. The product categories of the company include blood products, biochemical drugs, chemical medicines and others. Some of the company's blood products include human albumin, rabies immunoglobulin, intravenous human immunoglobulin and human fibrinogen.

Executives

Liang Xiao Ming	Directors, executives
Li Shou Sun	Executives
Zhang Shi Fang	Executives
Tu Yan Shi	Directors, executives
Chen Bing	Executives
Liao Xin Xi	Directors, executives
Fan Yi Qin	Secretary, Director
Jiang Guo Liang	Supervisors
Xu Jian Xin	Director
Duan Hong Zhuan	Executives
Chen Hai Yan	Executives
Hong Da Cheng	Director

China Resources Boya Bio-pharmaceutical Group Co Headlines

No Headlines